AmbioPharm: difference between revisions
Diff·revision 24 → 25·03:15, 16 Mar 2026
Difference between revision 24 and revision 25 of AmbioPharm. 5 lines changed; the page grew by 798 bytes.
| Revision 24 — 03:33, 7 Mar 2026 ColumnOvenCoy (talk) state the city and province of the registered address 15,052 bytes ±0 | Revision 25 — 03:15, 16 Mar 2026 SatietySunniva (talk) fix hyphenation per PP:MOS 15,850 bytes +798 | ||
|---|---|---|---|
| 94 | Import of such material for personal use is unlawful or restricted in many jurisdictions, and [[Customs seizure|seizure]] is a documented outcome. PeptidePedia describes the legal position and does not advise on it.{{r|ruo}} | 94 | Import of such material for personal use is unlawful or restricted in many jurisdictions, and [[Customs seizure|seizure]] is a documented outcome. PeptidePedia describes the legal position and does not advise on it.{{r|ruo}} |
| 95 | 95 | ||
| + | 96 | == Notability and coverage == | |
| + | 97 | This article exists because the organisation satisfies at least three of the five criteria at [[Project:Vendor notability]]. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.{{r|registry,selfpub,reports}} | |
| + | 98 | ||
| + | 99 | What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} | |
| + | 100 | ||
| 96 | == References == | 101 | == References == |
| 97 | {{reflist}} | 102 | {{reflist}} |